Chondroitin, ein Glycosaminoglycan (GAG), ist eine Polysaccharidkette aus alternierenden N-Acetylgalactosamin-(GalNAc-) und Glucuronsäure-(GlcA-)Einheiten, die an einer der bzw. an beiden GalNAc- und GlcA-Einheiten sulfatiert werden kann. Chondroitin und seine Sulfate sind häufig an Proteine gebunden und bilden so Proteoglycane.
Sonstige Hinweise
Für einen umfassenden Überblick über unser vielfältiges Angebot an Polysacchariden für Ihre Forschung empfehlen wir Ihnen den Besuch unserer Seite zur Kategorie Kohlenhydrate.
Biochimica et biophysica acta, 1830(10), 4719-4733 (2013-06-19)
Chondroitin sulfate proteoglycans (CSPGs) are principal pericellular and extracellular components that form regulatory milieu involving numerous biological and pathophysiological phenomena. Diverse functions of CSPGs can be mainly attributed to structural variability of their polysaccharide moieties, chondroitin sulfate glycosaminoglycans (CS-GAG). Comprehensive
The Journal of biological chemistry, 288(38), 27384-27395 (2013-08-14)
Chondroitin sulfate (CS) and the CS-rich extracellular matrix structures called perineuronal nets (PNNs) restrict plasticity and regeneration in the CNS. Plasticity is enhanced by chondroitinase ABC treatment that removes CS from its core protein in the chondroitin sulfate proteoglycans or
Biochimica et biophysica acta, 1830(10), 4806-4812 (2013-07-03)
Previously, we identified two missense mutations in the chondroitin N-acetylgalactosaminyltransferase-1 gene in patients with neuropathy. These mutations are associated with a profound decrease in chondroitin N-acetylgalactosaminyltransferase-1 enzyme activity. Here, we describe a patient with neuropathy who is heterozygous for a
Chondroitin sulfate proteoglycans (CSPGs) consist of a core protein and glycosaminoglycan (GAG) chains. There is enormous structural diversity among CSPGs due to variation in the core protein, the number of GAG chains and the extent and position of sulfation. Most
Human cysteine cathepsin S (catS) participates in distinct physiological and pathophysiological cellular processes and is considered as a valuable therapeutic target in autoimmune diseases, cancer, atherosclerosis, and asthma. We evaluated the capacity of negatively charged glycosaminoglycans (heparin, heparan sulfate, chondroitin
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..